Simcere Zaiming signs exclusive global licensing deal with Roche for SIM0660
Simcere Zaiming said it entered an exclusive global licensing agreement with Roche for the development and commercialization of SIM0660, a tri-specific antibody targeting C…
NANJING, China, Sept.
1, 2026 // -- Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group (2096.HK) today announced that it has entered into an exclusive global licensing agreement with Roche for the development and commercialization of SIM0660, a tri-specific antibody targeting C…